Hodgkin's Disease [clinicaltrials_resource:b8ba4e1398f5d30003f4053c04b95358]
Phase II Study of Filgrastim (G-CSF) Plus ABVD in the Treatment of HIV-Associated Hodgkin's Disease [clinicaltrials:NCT00000626]A Randomized Study of EPOCH II Versus EPOCH II and Immunotherapy in Lymphomas [clinicaltrials:NCT00001430]clinicaltrials:NCT00001575Donor Th2 Cells to Prevent Graft-Versus-Host Disease in Bone Marrow Transplants [clinicaltrials:NCT00001830]CD8 DLI for Patients With Relapse or Residual Disease Following Allogeneic Stem Cell Transplantation [clinicaltrials:NCT00038818]clinicaltrials:NCT00129753Establishing a Tumor Bank in Families With Multiple Lymphoproliferative Malignancies [clinicaltrials:NCT00131014]Study of Unrelated Cord Blood Transplantation Using Tacrolimus and Sirolimus [clinicaltrials:NCT00133367]clinicaltrials:NCT00136474Sirolimus With Tacrolimus for Graft-vs-Host Disease Prophylaxis After Un-Related Stem Cell Transplantation [clinicaltrials:NCT00144677]Sirolimus With Tacrolimus for Graft-vs-Host Disease Prophylaxis After Related Stem Cell Transplantation [clinicaltrials:NCT00144703]Study of Prednisone, Vinblastine, Doxorubicin, and Gemcitabine in Elderly Patients With Advanced Stages Hodgkin's Lymphoma [clinicaltrials:NCT00147875]Efficacy and Treatment Related Toxicity Study of a New Regimen for Lymphoma [clinicaltrials:NCT00163748]Efficacy Study of Outpatient Therapy for Lymphoma [clinicaltrials:NCT00163761]Mantle Irradiation for Hodgkin's Disease [clinicaltrials:NCT00165269]Tamoxifen in the Prevention of Breast Cancer in Hodgkin's Disease Survivors [clinicaltrials:NCT00165308]Breast MRI Screening in Women Treated With Mediastinal Irradiation for Hodgkin's Disease [clinicaltrials:NCT00165412]Cardiac Screening in Survivors of Hodgkin's Disease Treated With Mediastinal Irradiation [clinicaltrials:NCT00165425]Pulmonary Function in Patients With Hodgkin's Disease Receiving Bleomycin-Based Chemotherapy [clinicaltrials:NCT00165438]clinicaltrials:NCT00176930clinicaltrials:NCT00179816Phase II Trial of Thalidomide in Refractory/Relapsed Diffuse Large B-Cell Lymphoma and Hodgkin's Disease [clinicaltrials:NCT00209014]Reproducibility of an Immobilization Device (BodyFIX) - Hodgkins/Lymphoma [clinicaltrials:NCT00232440]Study of TPI 287 Administered Every 21 Days in Patients With Advanced Malignancies [clinicaltrials:NCT00256191]clinicaltrials:NCT00284804A Study of SB-743921 in Non-Hodgkin's Lymphoma [clinicaltrials:NCT00343564]clinicaltrials:NCT00368082Allogeneic Blood Stem Cell Transplantation and Adoptive Immunotherapy for Hodgkin's Disease [clinicaltrials:NCT00385788]Psychosocial Impact of Cancer-Related Female Infertility [clinicaltrials:NCT00386217]clinicaltrials:NCT00396201Clinical and Pathologic Studies in Non-Hodgkin's Lymphoma and Hodgkin's Disease [clinicaltrials:NCT00398177]Allogeneic Blood Stem Cell Transplantation [clinicaltrials:NCT00423709]Allogeneic Cytokine-induced Killer Immunotherapy for Relapse After Allogeneic Marrow Transplant for Haematological Malignancies [clinicaltrials:NCT00460694]clinicaltrials:NCT00469729clinicaltrials:NCT00484874Prediction of the Response to Chemotherapy by Tomoscintigraphie the MIBI in the Balance Sheet Pre Hodgkin's Disease and Lymphoma Malins High Grade [clinicaltrials:NCT00551798]Pulmonary Function at Presentation and Follow-up in Hemato-Oncology 3-7 Years Old Children [clinicaltrials:NCT00552825]Investigation of the Cylex® ImmuKnow® Assay [clinicaltrials:NCT00569842]Behavioral Intervention For BMT/SCT Survivors [clinicaltrials:NCT00579917]Spectroscopy With Surface Coils and Decoupling [clinicaltrials:NCT00581815]
condition [clinicaltrials_vocabulary:condition]
eligibility for clinicaltrials:NCT00660166 [clinicaltrials_resource:1786032b4154028328a3baf181228dd6]eligibility for clinicaltrials:NCT01622556 [clinicaltrials_resource:45f4e00e18f98d4454588424ee095200]eligibility for clinicaltrials:NCT00861965 [clinicaltrials_resource:54b2bb9841553e29e7c65814c3b5ca5d]
exclusion criteria [clinicaltrials_vocabulary:exclusion-criteria]
eligibility for clinicaltrials:NCT00660166 [clinicaltrials_resource:1786032b4154028328a3baf181228dd6]eligibility for clinicaltrials:NCT01622556 [clinicaltrials_resource:45f4e00e18f98d4454588424ee095200]eligibility for clinicaltrials:NCT00861965 [clinicaltrials_resource:54b2bb9841553e29e7c65814c3b5ca5d]
inclusion criteria [clinicaltrials_vocabulary:inclusion-criteria]
Hodgkin's Disease [clinicaltrials_resource:b8ba4e1398f5d30003f4053c04b95358]
Bio2RDF identifier
b8ba4e1398f5d30003f4053c04b95358
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:b8ba4e1398f5d30003f4053c04b95358
identifier
clinicaltrials_resource:b8ba4e1398f5d30003f4053c04b95358
title
Hodgkin's Disease
@en
label
Hodgkin's Disease [clinicaltrials_resource:b8ba4e1398f5d30003f4053c04b95358]
@en